Admissions and credentials

New York

Experience

CHARM Therapeutics Secures $80 Million Series B

September 2, 2025

Cooley advised CHARM Therapeutics, a biotechnology company pioneering the next generation of precision oncology treatments through its proprietary artificial intelligence-driven drug discovery platform, on its $80 million Series B financing, to advance its next-generation menin inhibitor into clinical development.

Read more

Related contacts

Jason Kent
Partner, New York
Eric Blanchard
Partner, Boston
Yoon Soo (Peter) Shin
Associate, New York
Lois NaYeon Yoo
Associate, New York
Jim Fulton
Partner, New York
Stephanie Gentile
Partner, New York
Christopher Kimball
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Harriet Fraser
Associate, New York
Calvin Lee
Associate, New York
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

Contentsquare Enters Definitive Agreement to Acquire Loris AI

July 30, 2025

Cooley advised Contentsquare, an all-in-one experience intelligence platform, on its definitive agreement to acquire Loris AI, a conversation intelligence platform, to give business leaders a deeper, more accurate view of the full customer journey – from click to conversation.

Read more

Related contacts

Izzy Lubarsky
Partner, New York
Stephane Levy
Partner, New York
Wesley Dietrich
Associate, Washington, DC
Matthew Choy
Associate, New York
Melanie Simon-Giblin
Associate, New York
Nyron J. Persaud
Partner, New York
Xander Lee
Partner, Santa Monica
Len Jacoby
Partner, New York
Karen Tsai
Special Counsel, Washington, DC
Kristen Mathews
Partner, New York
Christopher Kimball
Partner, Washington, DC
Phil Mitchell
Partner, New York
Stella Sarma
Partner, Brussels
Robert Jacques
Special Counsel, Washington, DC
Cara Buchicchio
Associate, New York
Sharon Davidov
Associate, New York
Mari Dugas
Associate, Washington, DC
Harriet Fraser
Associate, New York
Wyatt Kernell
Associate, Colorado
Bomin Kim
Associate, New York
Allison Kutner
Associate, New York
Shante Mays
Associate, Reston
Greg Reith
Associate, Washington, DC
Shelby Saunders
Associate, New York
Patrick Sharma
Associate, Santa Monica
Steven A. Zuckerman
Associate, New York
Patricia Myers
Paralegal Specialist, Colorado
Brandon Lefebvre
Quantitative Analyst, Boston

Related Practices & Industries

Runwise Secures $55 Million Series B

June 9, 2025

Cooley advised Runwise, a smart operating system for buildings, on its $55 million Series B financing round, bringing the company’s total funding to $79 million.

Read more

Related contacts

Roy Moran
Partner, New York
Michael Bruno
Associate, New York
Harriet Fraser
Associate, New York
Greg Reith
Associate, Washington, DC
Christopher Kimball
Partner, Washington, DC
Jonathan Rivinus
Partner, Colorado
Chris Chynoweth
Special Counsel, New York
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries

HAYA Therapeutics Closes $65 Million Series A

May 8, 2025

Cooley advised HAYA Therapeutics, a biotechnology company pioneering precision RNA-guided regulatory genome-targeting therapeutics, on its $65 million Series A financing round. The round was led by Sofinnova Partners and Earlybird Venture Capital, with participation from Eli Lilly and Company, ATHOS, +ND Capital, Alexandria Venture Investments, and LifeLink Ventures, with additional support from existing investors Apollo Health Ventures, Longview Ventures (an affiliate of Broadview Ventures), 4see ventures, BERNINA Bioinvest and Schroders Capital.

Lawyers Danielle Gershowitz, Josh Seidenfeld, Amanda Gonzalez Burton, Kristine Kevorkova and Thomas Heiser led the Cooley team advising HAYA Therapeutics.

Related contacts

Danielle Gershowitz
Partner, New York
Josh Seidenfeld
Partner, Palo Alto
Amanda Gonzalez Burton
Associate, New York
Kristine Kevorkova
Associate, Santa Monica
Thomas Heiser
Associate, Palo Alto
Harriet Fraser
Associate, New York

Related Practices & Industries

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.